Regulatory Approvals

Scholar Rock wins FDA approval for first drug to target SMA muscle loss

By

Regulatory Approvals — Scholar Rock wins FDA approval for first drug to target SMA muscle loss  STAT

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 12, 2026.

By

Related Post

Regulatory Approvals

Scholar Rock wins FDA approval for ISEMBYLD, the first muscle-targeted treatment for spinal muscular atrophy

Regulatory Approvals

FDA Approves Apitegromab for Spinal Muscular Atrophy

Regulatory Approvals

FDA approves first-of-its-kind drug rusfertide for polycythemia vera

Financial News For All

Regulation

Vorys Benefits Brief: Recent Court Decisions Affecting Withdrawal Liability

Regulation

Joint Readout of Principals’ Meeting of U.S. and UK Authorities Regarding Central Counterparty Resolution

Regulation

EPA begins cleanup at Rumsey Mill in Montana

Business Economy Finance

Commodities Price Update: Crude Oil $100.05, Brent $104.61, Copper $6.55, Coal $104.75 — Sep 12, 2026 8:00 AM EDT